| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 4.49e-05 | 53 | 27 | 3 | GO:1902041 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 5.91e-05 | 9 | 27 | 2 | GO:0140212 | |
| GeneOntologyCellularComponent | fibrinogen complex | 4.82e-05 | 8 | 28 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.95e-04 | 656 | 28 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.98e-04 | 658 | 28 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 8.90e-04 | 33 | 28 | 2 | GO:0044665 | |
| GeneOntologyCellularComponent | cell surface | 3.06e-03 | 1111 | 28 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 3.62e-03 | 67 | 28 | 2 | GO:0031093 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.52e-03 | 75 | 28 | 2 | GO:0035097 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.16e-03 | 530 | 28 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | side of membrane | 5.60e-03 | 875 | 28 | 5 | GO:0098552 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 6.17e-03 | 88 | 28 | 2 | GO:0016529 | |
| GeneOntologyCellularComponent | platelet alpha granule | 6.86e-03 | 93 | 28 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | methyltransferase complex | 9.16e-03 | 108 | 28 | 2 | GO:0034708 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.02e-02 | 114 | 28 | 2 | GO:0016528 | |
| Domain | Alkaline_phosphatase_core | 1.05e-03 | 31 | 29 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 1.05e-03 | 31 | 29 | 2 | IPR017849 | |
| Domain | - | 1.05e-03 | 31 | 29 | 2 | 3.40.720.10 | |
| Domain | VWC | 1.58e-03 | 38 | 29 | 2 | SM00214 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 29 | 2 | IPR001007 | |
| Domain | TSP_1 | 4.29e-03 | 63 | 29 | 2 | PF00090 | |
| Domain | TSP1 | 4.56e-03 | 65 | 29 | 2 | SM00209 | |
| Domain | TSP1_rpt | 4.56e-03 | 65 | 29 | 2 | IPR000884 | |
| Domain | TSP1 | 4.56e-03 | 65 | 29 | 2 | PS50092 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 6777381 | ||
| Pubmed | Dysregulated cell signalling and reduced satellite cell potential in ageing muscle. | 4.41e-05 | 12 | 29 | 2 | 31647919 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.09e-05 | 86 | 29 | 3 | 28327460 | |
| Pubmed | 5.98e-05 | 257 | 29 | 4 | 16335952 | ||
| Pubmed | 7.88e-05 | 276 | 29 | 4 | 28319085 | ||
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 2355006 | ||
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 1.26e-04 | 20 | 29 | 2 | 17082620 | |
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 12560567 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 1.53e-04 | 22 | 29 | 2 | 9109416 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 11530211 | ||
| Pubmed | 1.68e-04 | 23 | 29 | 2 | 1736542 | ||
| Pubmed | 1.68e-04 | 23 | 29 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 1.68e-04 | 23 | 29 | 2 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 1.68e-04 | 23 | 29 | 2 | 3264072 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.99e-04 | 25 | 29 | 2 | 2283726 | |
| Pubmed | 2.15e-04 | 26 | 29 | 2 | 8218172 | ||
| Pubmed | Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. | 2.33e-04 | 27 | 29 | 2 | 23144326 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.44e-04 | 146 | 29 | 3 | 23892456 | |
| Pubmed | SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. | 2.69e-04 | 29 | 29 | 2 | 17928865 | |
| Pubmed | 2.88e-04 | 30 | 29 | 2 | 20083228 | ||
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 3.32e-04 | 162 | 29 | 3 | 16502470 | |
| Pubmed | 4.39e-04 | 37 | 29 | 2 | 2542563 | ||
| Pubmed | 4.39e-04 | 37 | 29 | 2 | 2541446 | ||
| Pubmed | 4.63e-04 | 38 | 29 | 2 | 2829950 | ||
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 4.63e-04 | 38 | 29 | 2 | 16263699 | |
| Pubmed | Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. | 4.63e-04 | 38 | 29 | 2 | 2187500 | |
| Pubmed | 5.39e-04 | 41 | 29 | 2 | 16740002 | ||
| Pubmed | 5.93e-04 | 43 | 29 | 2 | 33472061 | ||
| Pubmed | 6.59e-04 | 205 | 29 | 3 | 20436479 | ||
| Pubmed | Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. | 6.79e-04 | 46 | 29 | 2 | 2649653 | |
| Pubmed | 7.37e-04 | 497 | 29 | 4 | 23414517 | ||
| Cytoband | 19q13.1 | 5.60e-04 | 55 | 29 | 2 | 19q13.1 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.68e-02 | 181 | 20 | 2 | 694 | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 7.93e-06 | 198 | 29 | 4 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 7.93e-06 | 198 | 29 | 4 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 154 | 29 | 3 | 73de626b210ec5482ba89a65e784c1e77ff2894e | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 154 | 29 | 3 | 56fe9953e58f71626d3ddf63d340ed35dfc4ce9f | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 29 | 3 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 29 | 3 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 29 | 3 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 161 | 29 | 3 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 163 | 29 | 3 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd8+_T_cell)|Lymphoid / shred on cell class and cell subclass (v4) | 1.80e-04 | 170 | 29 | 3 | 20fd1a312c81c1bf3c5d2d6caf9b578e6b7a4171 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 1.83e-04 | 171 | 29 | 3 | 098a7fd387357c0d4e1a6169af4d24ef95b30018 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-04 | 173 | 29 | 3 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 1.93e-04 | 174 | 29 | 3 | 05d54a36772f096047521e16a89cc42ae48d2a1d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 175 | 29 | 3 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 178 | 29 | 3 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.20e-04 | 182 | 29 | 3 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 2.27e-04 | 184 | 29 | 3 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 184 | 29 | 3 | fc708a5c8a7b19fab973c72dc4383a7d30f8b59a | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 184 | 29 | 3 | 14a5288d861260f63fbe0cbea3569cf643e7597e | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 2.46e-04 | 189 | 29 | 3 | 74a5e61cd820f2495dde40e766c771a31d8c4e7d | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.46e-04 | 189 | 29 | 3 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 189 | 29 | 3 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-04 | 189 | 29 | 3 | 2e43428f1ef9683c6f8c9897d46aa7d34bf9047f | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.50e-04 | 190 | 29 | 3 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.50e-04 | 190 | 29 | 3 | 1f907016980ccfbf089e354d91d931771e8a83e0 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.50e-04 | 190 | 29 | 3 | 00ef6ec71353e42260c0d807d7da65b63154c288 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.50e-04 | 190 | 29 | 3 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.50e-04 | 190 | 29 | 3 | 18c020ca9a23399214133ec255ab870e0060f2e1 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-04 | 191 | 29 | 3 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-04 | 191 | 29 | 3 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-04 | 191 | 29 | 3 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.62e-04 | 193 | 29 | 3 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-04 | 193 | 29 | 3 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 193 | 29 | 3 | a50ee6110ea272d9d9f41d48bb5d43711cc00a32 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.66e-04 | 194 | 29 | 3 | a94f9f7179a5733e3c378ff8b337e288785433a1 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.66e-04 | 194 | 29 | 3 | 1ca034f25a8fce503fb67654d7fa2a8ec71976be | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.66e-04 | 194 | 29 | 3 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Classical_Monocyte|Control / Disease condition and Cell class | 2.66e-04 | 194 | 29 | 3 | 9e33e1b54b4114f9e6981819834bb796ed7192b5 | |
| ToppCell | BLOOD--(3)_Classical_Mono-1| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.70e-04 | 195 | 29 | 3 | 4702d234731d4cd47d5fba570e439deee21c67f9 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-04 | 195 | 29 | 3 | 403d874198a7bde626b0d0b4efad8dbb34060761 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-04 | 195 | 29 | 3 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | (7)_Monocyte|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.74e-04 | 196 | 29 | 3 | 0232167559dcd2d86ee8b78017cf5f2a084b2cb7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-04 | 196 | 29 | 3 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-04 | 196 | 29 | 3 | 89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-04 | 196 | 29 | 3 | 5842d6fa0c066815d7d8c7e59b192bfc72960707 | |
| ToppCell | Influenza_Severe|World / Disease group and Cell class | 2.74e-04 | 196 | 29 | 3 | 6a8ecb524f55212a91060d45ab8612f3f677e543 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-04 | 196 | 29 | 3 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-04 | 196 | 29 | 3 | 09574bfeb1d3da53b5471cfb0602946d328b3b5c | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-04 | 196 | 29 | 3 | 8608be3c3e7fd776c5f2fae207cd0b801e138349 | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 197 | 29 | 3 | cd941c5ef76897047bd8508d98510c4ff164d223 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-04 | 197 | 29 | 3 | 0c059476a8cdc6ac71a01d9c414295177f45f8de | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-04 | 197 | 29 | 3 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-04 | 197 | 29 | 3 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | Influenza_Severe-Classical_Monocyte|World / Disease group and Cell class | 2.78e-04 | 197 | 29 | 3 | e9a01f0fbbeaf6b23bce4603f62053c003848da4 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 2.78e-04 | 197 | 29 | 3 | dcf0009057576a7db9065e644a3919d6de2ac8e6 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-04 | 198 | 29 | 3 | 100091c91fde604daf110f20b44505f240f93ae8 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | 74591eba5dbb2d77d416309326a26be969e4ad42 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 2.82e-04 | 198 | 29 | 3 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 4b6767bd6fd4bd43eed18fd4a34c20923fa795da | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | f3346c26b9647a199faf3cd7ab19c3a963dbabc2 | |
| ToppCell | (4)_Monocyte|World / shred on Cell_type and subtype | 2.82e-04 | 198 | 29 | 3 | 56f9ebf902fe81c590696ba4c88028deaf346841 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 2.82e-04 | 198 | 29 | 3 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 18daf83309813f914b17bd226ea8a9269a26b107 | |
| ToppCell | proximal-Hematologic-Classical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-04 | 198 | 29 | 3 | 6a7ca6eef6b74aa7fc3aec84e9ffd0beedaa589b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 72c7474e084d1334a09c0a3b0f3c3137038794c8 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | 3e1e79bb7b13540a06956b59c6a62984efea19ee | |
| ToppCell | proximal-3-Hematologic-Classical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-04 | 198 | 29 | 3 | 6c6a63b8ec03b7a8f46b70bf13261fab56355f92 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-04 | 198 | 29 | 3 | 73e9ada6998c09ae3a3a66e920b28694b7f9cf6b | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 2.82e-04 | 198 | 29 | 3 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | a7145565703d0e036d2dcef5dba6d86f200845c9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | c288b29287a562460d8970264e1833801590da73 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 2.82e-04 | 198 | 29 | 3 | 934dacb67d71faa2f8732c39d7f8e64b0ee75396 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.82e-04 | 198 | 29 | 3 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | proximal-Hematologic-Classical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-04 | 198 | 29 | 3 | 98bd2b3e03ab659ce163d5773660ce008e4cc2ca | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 2.82e-04 | 198 | 29 | 3 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-04 | 199 | 29 | 3 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 2.86e-04 | 199 | 29 | 3 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | ef1a0c278c23614fd6a3218a9733abe6ecd6f686 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.86e-04 | 199 | 29 | 3 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.86e-04 | 199 | 29 | 3 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-CD14_monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-04 | 199 | 29 | 3 | 50a30d5ee99e51743a0dd60144fc341ff68da9af | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.86e-04 | 199 | 29 | 3 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 2.86e-04 | 199 | 29 | 3 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic-Classical_monocytes|blood / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | cd4528ae4a4d8ed1da20b268c556ab9b3f03c374 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.86e-04 | 199 | 29 | 3 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 2.86e-04 | 199 | 29 | 3 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 2.86e-04 | 199 | 29 | 3 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-04 | 199 | 29 | 3 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic-Classical_monocytes|Liver / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 46491e8e76aa4d7ada036946f93cf71609c85462 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Classical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 2c747e9265594e12d46bd8c8de75c45e83144155 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-04 | 199 | 29 | 3 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Classical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 93f25e8f22deb438c930c2e95e572dbd16503f71 | |
| ToppCell | severe_influenza-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.86e-04 | 199 | 29 | 3 | b8adbd6ff5e5602259118a69fd7c77e8348a27e4 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 2.86e-04 | 199 | 29 | 3 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 200 | 29 | 3 | 9e8659bbc6547f1ab7f4e0a81b0bcbe158e9e2f7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | d237cf947d6768b022d18211e14af4adb4990708 | |
| Drug | Piperlongumine [20069-09-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.36e-05 | 178 | 29 | 4 | 2757_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 9.87e-05 | 192 | 29 | 4 | 6990_DN | |
| Drug | Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 9.87e-05 | 192 | 29 | 4 | 2785_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 4331_DN | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; HL60; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 2997_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 5765_DN | |
| Drug | genistein; Down 200; 10uM; PC3; HG-U133A | 1.09e-04 | 197 | 29 | 4 | 703_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 2468_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6200_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 1816_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 4523_DN | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; HL60; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 2476_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; HL60; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 2577_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 1.16e-04 | 200 | 29 | 4 | 1953_DN | |
| Drug | cast 3 | 1.21e-04 | 13 | 29 | 2 | CID000072360 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.98e-03 | 67 | 29 | 2 | EFO_0008595, EFO_0020946 | |
| Disease | metabolite measurement, diet measurement | 2.22e-03 | 71 | 29 | 2 | EFO_0004725, EFO_0008111 | |
| Disease | neuroimaging measurement | 3.56e-03 | 1069 | 29 | 5 | EFO_0004346 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 4.61e-03 | 103 | 29 | 2 | EFO_0008595, EFO_0020944 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 6.30e-03 | 121 | 29 | 2 | EFO_0008595, EFO_0020943 | |
| Disease | vital capacity | 6.57e-03 | 1236 | 29 | 5 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGSWKWVDGTDYRHN | 241 | P07307 | |
| WGYREHNGPIHWKEF | 6 | Q8N1Q1 | |
| YHWKRWPLMNDEGED | 1046 | Q8TDJ6 | |
| NKHRVDGSWAKWDPY | 511 | Q8TE58 | |
| DNHRYKWNGRWWEPS | 131 | Q8IWI9 | |
| ANWGGARAEPGKFWH | 11 | Q92485 | |
| KEDGGGWWYNRCHAA | 426 | P02675 | |
| WDDWKDTHPRGYGNR | 321 | P78318 | |
| GWFDAHDPKYWRRST | 1506 | Q9UMN6 | |
| ERWGPGRFDYWGNSH | 226 | Q8N4S7 | |
| RNSEHDPPYWRGAVW | 741 | Q13724 | |
| WWYLDRDKPRQGGRH | 56 | Q3SYC2 | |
| AWEGKGVSYWRVPHE | 216 | Q6PI47 | |
| WLWGDPHYHSFDGRK | 4076 | Q9Y6R7 | |
| LEKGDYPRWDAWSNS | 81 | P26998 | |
| HDPRYRQWGWEAALA | 546 | O60476 | |
| REGWQRGWHGYDNEL | 346 | Q6UWR7 | |
| RDNYSPGWKFNHWEL | 1346 | P07814 | |
| YHAGKEEDSKTWPWG | 1031 | A0AVI2 | |
| WPDARGIWHNDNKSF | 211 | P06732 | |
| DYHRQTPGWAWEDRP | 2361 | O75376 | |
| KDQDGWEPLHAAAYW | 261 | Q96I34 | |
| WDWQHVGPGYRDRSY | 91 | O60936 | |
| DPRHIGWKDFTAYRW | 1096 | P07996 | |
| KDPEAWSRPQGWYNH | 501 | Q9Y572 | |
| YHRDEGWKWGGCSAD | 141 | O00755 | |
| HPSSDAWKGENWLYR | 261 | Q9UL58 | |
| GSYDLHRGQLWDGWE | 856 | Q8IWU6 | |
| FSRPGGRHAAEGKWW | 521 | Q96S06 |